Looking Into Alnylam Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Alnylam Pharmaceuticals (NYSE:ALNY) has seen an 18.05% increase in its short percent of float, now at 3.99% of available shares. This indicates a rise in bearish sentiment, although it remains below the peer group average of 5.86%.
September 26, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alnylam Pharmaceuticals has experienced an 18.05% increase in short interest, now at 3.99% of its float. This suggests a rise in bearish sentiment, but the short interest is still below the peer average of 5.86%.
The increase in short interest suggests that investors are becoming more bearish on Alnylam Pharmaceuticals. However, since the short interest is still below the peer average, the impact might be less severe. The stock may face downward pressure in the short term due to increased bearish sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100